Table 4 Clinical outcomes by treatment subgroup
Outcome | No treatment (n = 6) | Prednisone and MMF (n = 12) | Other immunosuppression (n = 8) |
|---|---|---|---|
Age at diagnosis, years (SD) | 50 (22) | 30 (20) | 61 (18) |
Gender, no. male (%) | 3 (50) | 8 (67) | 5 (63) |
Cr at diagnosis, umol/L (IQR) | 225 (260) | 165 (232) | 215 (153) |
Proteinuria, mg/mmol (IQR) | 903 (895) | 583 (687) | 212 (584) |
Dialysis at diagnosis, no. (%) | 1 (4) | 0 (0) | 1 (4) |
Patterns of disease on light microscopy (n) | MPGN (5), MsPGN (1) | MPGN (8), DPGN (4) | MPGN (5), DPGN (1), MsPGN (2) |
Complete remission, no. (%) | 1 (17) | 2 (17) | 3 (38) |
Stable disease, no. (%) | 2 (33) | 7 (58) | 3 (38) |
Progressive disease, no.(%) | 2 (17) | 2 (17) | 1 (13) |
Occurrence of ESRD, no. (%) | 3 (50) | 3 (25) | 1 (13) |
Renal survival, no. (%) | 3 (50) | 9 (75) | 7 (88) |